SFG
AGIO icon

Steward Financial Group’s Agios Pharmaceuticals AGIO Stock Holding History

Steward Financial Group’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$0 Buy
+9
New +$238 ﹤0.01% 1315
2023
Q2 		– Sell
-9
Closed – – 417
2023
Q1 		$0 Buy
9
+4
+80% +$106 ﹤0.01% 700
2022
Q4 		$0 Buy
+5
New +$141 ﹤0.01% 523
2022
Q3 		– Sell
-5
Closed – – 87
2022
Q2 		$0 Buy
+5
New +$113 ﹤0.01% 948

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Steward Financial Group's AGIO Position: Q3 2023 in Review

Steward Financial Group opened a new position in Agios Pharmaceuticals (AGIO) in Q3 2023: 9 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1315 among its holdings. This is a return to the name: Steward Financial Group previously reported a position in AGIO as recently as Q1 2023.

Steward Financial Group first reported a position in AGIO in Q2 2022 and has held it in 4 quarters since. 144 funds tracked by Wall St. Rank hold AGIO as of Q3 2023.

  • Steward Financial Group held 9 shares of Agios Pharmaceuticals worth $0 as of Q3 2023.
  • Agios Pharmaceuticals was a new Steward Financial Group position in Q3 2023.
  • Agios Pharmaceuticals made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #1315 holding.
  • Steward Financial Group first reported a position in Agios Pharmaceuticals in Q2 2022 and has held it in 4 quarters since.
  • 144 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.